Healthcare Services

Apolipoprotein Testing Market Revenue Growth Expected to Reach $4.08 Billion by 2030 with 5.5% CAGR

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Apolipoprotein Testing Market Evolve From 2026 To 2030?

The apolipoprotein testing market has demonstrated robust growth in recent years. It is projected to expand from $3.11 billion in 2025 to $3.29 billion in 2026, showing a compound annual growth rate (CAGR) of 5.9%. This historical growth can be attributed to the increasing prevalence of cardiovascular diseases, the wider adoption of lipid testing protocols, the expansion of diagnostic laboratory networks, a growing awareness of preventive healthcare, and the availability of standardized apolipoprotein assays.

The apolipoprotein testing market is anticipated to experience robust expansion over the next few years, projected to reach $4.09 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.5%. This growth during the forecast period is primarily fueled by a rising need for precise cardiovascular diagnostics, the increasing integration of molecular diagnostics into standard testing, the broadening application of personalized medicine approaches, growing investments in automated diagnostic technologies, and an increased emphasis on early disease risk stratification. Significant trends expected during this period include a greater uptake of advanced lipid risk assessment tests, an escalating demand for preventive cardiovascular diagnostics, the increasing integration of genetic and protein testing, the wider deployment of automated immunoassay platforms, and a reinforced focus on personalized cardiac risk profiling.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19293&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Apolipoprotein Testing Market?

The expanding occurrence of cardiovascular diseases is projected to boost the expansion of the apolipoprotein testing market in the future. Cardiovascular disease (CVD) encompasses a range of conditions affecting the heart and blood vessels, leading to issues such as heart attacks, strokes, and peripheral vascular disease. The increase in these disorders is attributed to various elements, including unhealthy eating patterns, rising rates of obesity, and an aging demographic. Apolipoproteins, including ApoA-I and ApoB, play a vital role in lipid transport within the bloodstream. Measuring their levels aids in evaluating cardiovascular disease risk and customizing lipid-lowering therapies for effective management. For instance, in January 2024, data from the American Heart Association, a US-based nonprofit organization, indicated that the age-adjusted mortality rate from cardiovascular disease reached 233.3 per 100,000, representing a 4.0% increase from the prior year’s rate of 224.4 per 100,000, following a 4.6% increase in 2023. This marked the first such rise observed in many years. Consequently, the increasing incidence of cardiovascular diseases is a primary driver for the growth of the apolipoprotein testing market.

Which Segment Areas Are Covered In The Apolipoprotein Testing Market Analysis?

The apolipoprotein testing market covered in this report is segmented –

1) By Type Of Apolipoprotein: Apolipoprotein A-I, Apolipoprotein B, Apolipoprotein E

2) By Technology: Immunoassays, Polymerase Chain Reaction (PCR)

3) By Application: Cardiovascular Disease Risk Assessment, Genetic Testing, Other Applications

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes

Subsegments:

1) By Apolipoprotein A-I: Quantitative Testing, Qualitative Testing, Functional Testing

2) By Apolipoprotein B: Total Apolipoprotein B Testing, Apolipoprotein B100 Testing, Apolipoprotein B48 Testing

3) By Apolipoprotein E: Genotyping Tests, Protein Level Testing, Functional Assays

What Trends Are Projected To Affect The Apolipoprotein Testing Market?

Leading companies within the apolipoprotein market are introducing enhanced heart health plans to offer more comprehensive assessments and personalized recommendations for managing cholesterol levels and decreasing the risk of cardiovascular diseases. These improved wellness programs provide thorough evaluations and tailored suggestions to promote cardiovascular well-being. For example, in January 2023, InsideTracker, a US-based personal health analysis company, launched its Ultimate Plan, which now includes Apolipoprotein B (ApoB) measurement, a crucial indicator of heart health. This addition allows users to gain a deep understanding of their cardiovascular status, as elevated ApoB levels are associated with higher risks of atherosclerosis and heart disease. The plan offers users insights into their ApoB levels compared to standard ranges, along with customized lifestyle recommendations based on extensive research by InsideTracker’s science team.

Which Global Companies Are Actively Competing In The Apolipoprotein Testing Market?

Major companies operating in the apolipoprotein testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Bio-Rad Laboratories Inc., Randox Laboratories Ltd., R&D Systems Inc., Elabscience Bionovation Inc., Sekisui Diagnostics LLC, RayBiotech Inc., Mabtech AB, Bioss Inc., Aviva Systems Biology Corporation, Abnova Corporation, DiaSys Diagnostic Systems GmbH, Enzo Life Sciences Inc., Eagle Biosciences Inc., CLOUD-CLONE CORP., ELK Biotechnology CO. Ltd., LifeSpan BioSciences Inc.,

Read the full apolipoprotein testing market report here:

https://www.thebusinessresearchcompany.com/report/apolipoprotein-testing-global-market-report

What Are The Leading Geographic Regions In The Apolipoprotein Testing Market?

North America was the largest region in the apolipoprotein testing market in 2025. The regions covered in the apolipoprotein testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Apolipoprotein Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19293&type=smp

Browse Through More Reports Similar to the Global Apolipoprotein Testing Market 2026, By The Business Research Company

Pharmaceutical Sterility Testings Global Market Report

https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testings-global-market-report

Pcr And Realtime Pcr Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/pcr-and-realtime-pcr-testing-global-market-report

Prenatal Testing And Newborn Screening Global Market Report

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795